Access Pharmaceuticals (ACCP) Chariman, Steven Rouhandeh, on WallStreetCast

Access Pharmaceuticals, Inc. Chariman, Steven Rouhandeh, appeared on WALLSTREETCAST, a national weekly television program that airs on the FOX Business Network this past Saturday, November 20, 2010. Interview topics included MuGard™, Access' FDA-approved product for the management of patients with mucositis, ProLindac™, which is currently in Phase II clinical testing of patients with ovarian cancer, and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers.

Category:

Science & Technology

Tags:

• Access Pharma
• ACCP
• MuGard
• ProLindac
• Thiarabine
• WALLSTREETCAST